BiVictriX Therapeutics Plc carries a market capitalization of 8.25M, placing it among publicly traded companies globally.
| Market Cap | 8.25M |
| Enterprise Value | N/A |
BiVictriX Therapeutics Plc's stock has declined approximately -20% over the past 52 weeks. The 50-day moving average sits at 10.91, while the 200-day moving average is 10.73.
| Beta (5Y) | N/A |
| 52-Week Price Change | -20% |
| 50-Day Moving Average | 10.91 |
| 200-Day Moving Average | 10.73 |
| Average Volume (20 Days) | N/A |